ABT737 Reverses Cisplatin Resistance by Targeting Glucose Metabolism of Human Ovarian Cancer Cells

International Journal of Oncology - Greece
doi 10.3892/ijo.2018.4476
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

Cancer Research
Cancer ResearchOncology
2011English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

Role of Autophagy in Cisplatin Resistance in Ovarian Cancer Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

miR-625 Reverses Multidrug Resistance in Gastric Cancer Cells by Directly Targeting ALDH1A1

Cancer Management and Research
Oncology
2019English

Mitigating Cisplatin Resistance in Ovarian Cancer.

English

Restoration of miR-26b Expression Partially Reverses the Cisplatin Resistance of NSCLC by Targeting Tafazzin

OncoTargets and Therapy
OncologyPharmacology
2019English

Heparin Antagonizes Cisplatin Resistance of A2780 Ovarian Cancer Cells by Affecting the WNT Signaling Pathway

Oncotarget
Oncology
2017English

Cisplatin/Carboplatin Cross-Resistance in Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1989English

miRNA-378 Reverses Chemoresistance to Cisplatin in Lung Adenocarcinoma Cells by Targeting Secreted Clusterin

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy